AI infrastructure spending hit record levels last year, yet most retail investors still chase the obvious names like Nvidia (NASDAQ:NVDA | NVDA Price Prediction) or Broadcom (NASDAQ:AVGO). The real opportunity often sits one layer deeper — in the specialized equipment that makes those chips reliable at scale.
Aehr Test Systems (NASDAQ:AEHR) supplies wafer-level and package-level burn-in systems that test semiconductors under extreme conditions before they ship to hyperscale data centers. Its stock traded in a narrow range through most of 2025, closing the year at $20.19, ranging between $6.78 and $33.63 per share.
However, it began climbing again in early 2026, reached the mid-$30s once more by mid-March, then exploded higher on April 1 after a single announcement. The move looked random until you read the fine print. Here is exactly what changed — and why the next few earnings reports will finally show the payoff.
The Sideways Grind That Set the Stage
Aehr spent 2025 in classic small-cap limbo. Revenue came in lumpy because its chip designer customers place big orders only after lengthy qualification runs. The company reported fiscal 2026 first-quarter revenue of $11 million in October, which was down from $13.1 million the prior year. Shares barely budged.
That changed in January when management reinstated full-year guidance on the back of “improved visibility for AI processor and data center semiconductor test.” By March, the stock had already doubled its 2025 close. No broad market catalyst drove it — just steady order flow in silicon photonics and AI custom silicon. Investors who track backlog instead of quarterly revenue spotted the shift early.
One Order That Changed Everything
On March 31, though, Aehr announced an initial order from a global networking leader that supplies hyperscale data centers. The customer bought multiple FOX-XP wafer-level burn-in systems configured to test nine wafers in parallel, plus FOX-NP systems, WaferPak auto aligners, and full-wafer contactors. All gear targets advanced silicon-photonics transceivers used for high-speed optical links in AI clusters.
Shipments start in the fiscal fourth quarter ending May 29. Shares rose 12% to $33.78 in that session alone and kept climbing, closing April 1 at $39.60 per share. That single win validated Aehr’s pivot from legacy markets into the exact AI infrastructure niche exploding right now. It also explained Aehr’s pre-earnings surge: traders front-ran the backlog conversion that arrives in coming quarters.
Why Future Earnings Will Finally Reflect the Surge
Aehr’s business model means revenue lags orders by one to two quarters. The March 31 win, plus earlier follow-on orders from its lead silicon-photonics customer announced earlier, will hit the top line starting this quarter.
Fiscal third-quarter results released last night showed revenue of $10.3 million — down 44% year-over-year because of shipment timing — but bookings of $37.2 million produced a book-to-bill above 3.5 times. Effective backlog, including $12.2 million received since quarter-end, reached a record $50.9 million. Management guided full-year fiscal 2026 revenue to the high end of the prior $45 million to $50 million range and second-half bookings to the high end of $60 million to $80 million. Those numbers convert directly into fiscal 2027 growth. No matter how you slice it, the revenue ramp is now locked in.
Granted, the stock trades at a premium. Aehr carries a price-to-sales ratio of 37 on trailing 12-month revenue of $53.25 million and a market cap of $1.97 billion. Peers trade cheaper: Teradyne (NASDAQ:TER) has a price-to-earnings multiple of 100.3, FormFactor (NASDAQ:FORM) at 164, and Cohu (NASDAQ:COHU) is producing losses.
Although Aehr also still posts small GAAP losses — $0.29 per share over the last 12 months — a beta of 2.29 means it swings harder than the market. That said, its $37.1 million cash balance at quarter-end gives it runway while the backlog turns into cash flow.
Key Takeaway
In short, Aehr Test Systems is the AI stock many investors overlooked because its revenue prints lagged the order momentum. The March 31 silicon-photonics win and record $50.9 million effective backlog mean the next two quarters should deliver the acceleration that justifies today’s valuation.
Smart investors should take modest positions now, but track the May and August earnings for actual shipment numbers, and compare backlog conversion against guidance. If hyperscale demand holds, Aehr turns from sideways sleeper into a compounder. If orders slip, the high multiple leaves little margin for error. Either way, the data now points in one direction: higher.
Top Gaining Stocks
Top Losing Stocks